Amid a reckoning over the representation of women on the drug industry’s most prominent stages, this year’s BIO International Convention will feature a 30 percent increase in female speakers compared with last year.
But in a sign of how male-dominated such events remain, the conference will also have 25 panels made up entirely of men. That’s according to a count from GenderAvenger, a group that tracks gender diversity at events.
Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
